Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
IBUPROFEN REQUIRED NDA FOR OTC MARKETING BECAUSE IT IS NEW, 200 MG DOSE, FDA TELLS CHATTEM IN MAY 18 REJECTION OF CITIZEN PETITION; POLICY DEFENDED
May 21 1984
•
By
The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet